[Priority for atypical antipsychotics--comments on the article by Dose M. Priority for Atypicals? Current studies clarify some aspects. Psychiat Prax 2007; 34:46-49].
Fritze
Jürgen
J
juergen.fritze@dgn.de
Aldenhoff
Josef
J
Bergmann
Frank
F
Eckermann
Gabriel
G
Maier
Wolfgang
W
Möller
Hans-Jürgen
HJ
Gaebel
Wolfgang
W
D014150:Antipsychotic Agents / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D015982:Bias; D003363:Cost Control; D004305:Dose-Response Relationship, Drug; D016527:Drug Costs; D004409:Dyskinesia, Drug-Induced / Q000209:etiology; D005858:Germany; D006801:Humans; D009313:National Health Programs / Q000191:economics; D011618:Psychotic Disorders / Q000188:drug therapy* / Q000191:economics; D016032:Randomized Controlled Trials as Topic / Q000706:statistics & numerical data; D016896:Treatment Outcome
D014150:Antipsychotic Agents